loadpatents
name:-0.031943082809448
name:-0.032021045684814
name:-0.00067400932312012
HAFNER; Andreas Patent Filings

HAFNER; Andreas

Patent Applications and Registrations

Patent applications and USPTO patent grants for HAFNER; Andreas.The latest application filed is for "solar light management".

Company Profile
0.35.29
  • HAFNER; Andreas - Gelterkinden CH
  • Hafner; Andreas - Mainz DE
  • Hafner; Andreas - Gelterkinder DE
  • Hafner; Andreas - Gelterkinden BL N/A CH
  • Hafner; Andreas - Goppingen DE
  • Hafner; Andreas - Laupen CH
  • Hafner; Andreas - Frenkendorf CH
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Solar Light Management
App 20210333448 - HAFNER; Andreas ;   et al.
2021-10-28
Multi-component crystals of vismodegib and selected co-crystal formers or solvents
Grant 10,105,355 - Viertelhaus , et al. October 23, 2
2018-10-23
Multicomponent Crystals Of Dasatinib With Menthol Or Vanillin
App 20180230140 - VIERTELHAUS; Martin ;   et al.
2018-08-16
Solid form of abiraterone acetate
Grant 10,045,998 - Chiodo , et al. August 14, 2
2018-08-14
Salts of dasatinib in amorphous form
Grant 9,884,857 - Hafner , et al. February 6, 2
2018-02-06
Ir Reflective Film
App 20170363789 - STALDER; Martin ;   et al.
2017-12-21
Device and/or Method for Treating Diseases of the Skin, Glands, Mucosae, Connective Tissue, Nerves and/or Horny Tissue
App 20170340385 - Reinhard; Katharina ;   et al.
2017-11-30
Multi-component Crystals Of Vismodegib And Selected Co-crystal Formers Or Solvents
App 20170216266 - VIERTELHAUS; MARTIN ;   et al.
2017-08-03
Multicomponent crystalline system comprising nilotinib and selected co-crystal formers
Grant 9,567,317 - Chiodo , et al. February 14, 2
2017-02-14
Salts of Dasatinib in crystalline form
Grant 9,556,164 - Hafner , et al. January 31, 2
2017-01-31
Solid Form Of Abiraterone Acetate
App 20160303143 - CHIODO; Tiziana ;   et al.
2016-10-20
Salts Of Dasatinib In Amorphous Form
App 20160168142 - HAFNER; Andreas ;   et al.
2016-06-16
Solar Light Management
App 20160170102 - HAFNER; Andreas ;   et al.
2016-06-16
Salts Of Dasatinib In Crystalline Form
App 20160168143 - HAFNER; Andreas ;   et al.
2016-06-16
Multicomponent crystals comprising dasatinib and selected co-crystal formers
Grant 9,340,536 - Chiodo , et al. May 17, 2
2016-05-17
Multicomponent crystalline system comprising deferasirox and isonicotinamide and a process for the preparation thereof
Grant 9,290,452 - Hafner , et al. March 22, 2
2016-03-22
Multicomponent system of rosuvastatin calcium salt and sorbitol
Grant 9,249,108 - Hafner , et al. February 2, 2
2016-02-02
Multicomponent crystals comprising imatinib mesilate and selected co-crystal formers
Grant 9,221,789 - Chiodo , et al. December 29, 2
2015-12-29
Multicomponent Crystalline System Comprising Nilotinib And Selected Co-crystal Formers
App 20150246901 - Chiodo; Tiziana ;   et al.
2015-09-03
Multicomponent Crystalline System Comprising Deferasirox And Isonicotinamide And A Process For The Preparation Thereof
App 20150175544 - Hafner; Andreas ;   et al.
2015-06-25
Multicomponent Crystals Comprising Dasatinib And Selected Co-crystal Formers
App 20150133463 - Chiodo; Tiziana ;   et al.
2015-05-14
Multicomponent Crystals Comprising Imatinib Mesilate And Selected Co-crystal Formers
App 20150126520 - Chiodo; Tiziana ;   et al.
2015-05-07
Multicomponent Crystalline System Of Voriconazole With Fumaric Acid
App 20150087657 - Hafner; Andreas ;   et al.
2015-03-26
Methods in cell cultures, and related inventions, employing certain additives
Grant 8,859,235 - Kaufmann , et al. October 14, 2
2014-10-14
Multicomponent crystalline system of rosuvastatin calcium salt and vanillin
Grant 8,841,316 - Hafner , et al. September 23, 2
2014-09-23
Test arrangement
Grant 8,785,142 - Gubitz , et al. July 22, 2
2014-07-22
Multicomponent Crystalline System Of Rosuvastatin Calcium Salt And Vanillin
App 20140194453 - HAFNER; Andreas ;   et al.
2014-07-10
Compositions, use and method for the use of surface active proteins in topical drug delivery across keratin
Grant 8,758,730 - Buthe , et al. June 24, 2
2014-06-24
Multicomponent Crystalline System Of Ezetimibe And Proline
App 20140155371 - Hafner; Andreas ;   et al.
2014-06-05
Multicomponent crystalline system of rosuvastatin calcium salt and vanillin
Grant 8,716,305 - Hafner , et al. May 6, 2
2014-05-06
Multicomponent Crystalline System Of Rosuvastatin Calcium Salt And Vanillin
App 20140031377 - Hafner; Andreas ;   et al.
2014-01-30
Multicomponent System Of Resuvastatin Calcium Salt And Sorbitol
App 20130237553 - Hafner; Andreas ;   et al.
2013-09-12
Test Arrangement
App 20120309036 - Gubitz; Georg ;   et al.
2012-12-06
Surface active proteins as excipients in solid pharmaceutical formulations
Grant 8,226,967 - Buthe , et al. July 24, 2
2012-07-24
Methods In Cell Cultures, And Related Inventions, Employing Certain Additives
App 20120164162 - Kaufmann; Franz ;   et al.
2012-06-28
Compositions, Use And Method For The Use Of Surface Active Proteins In Topical Drug Delivery Across Keratin
App 20120058199 - Buthe; Andreas ;   et al.
2012-03-08
Surface Active Proteins As Excipients In Solid Pharmaceutical Formulations
App 20110268792 - Buthe; Andreas ;   et al.
2011-11-03
Amphiphilic Proteins As Morphology Modifiers
App 20110159050 - Hafner; Andreas ;   et al.
2011-06-30
Die consisting of PCBN or a CBN composite material comprising a clamping depression
App 20090035521 - Hafner; Andreas ;   et al.
2009-02-05
Process for the synthesis of amine ethers from secondary amino oxides
Grant 7,402,675 - Hafner , et al. July 22, 2
2008-07-22
Process for the synthesis of amine ethers from secondary amino oxides
Grant 6,900,328 - Hafner , et al. May 31, 2
2005-05-31
Process for the synthesis of amine ethers from secondary amino oxides
App 20050043552 - Hafner, Andreas ;   et al.
2005-02-24
Process for the preparation of ketimines
Grant 6,806,386 - Thommen , et al. October 19, 2
2004-10-19
Process for the preparation of ketimines
Grant 6,693,218 - Thommen , et al. February 17, 2
2004-02-17
Process for the synthesis of amine ethers from secondary amino oxides
App 20030171461 - Hafner, Andreas ;   et al.
2003-09-11
Ruthenium and osmium carbene carbonyl catalysts
Grant 6,465,554 - Van Der Schaaf , et al. October 15, 2
2002-10-15
Heterocyclyl ligand containing ruthenium and osmium catalysts
Grant 6,417,363 - Van Der Schaaf , et al. July 9, 2
2002-07-09
Ruthenium and osmium carbene catalysts
Grant 6,407,190 - Van Der Schaaf , et al. June 18, 2
2002-06-18
Ruthenium and osmium catalysts
Grant 6,306,987 - Van Der Schaaf , et al. October 23, 2
2001-10-23
Polymerizable composition, process for producing cross linked polymers, and cross-linkable polymers
Grant 6,281,307 - Muhlebach , et al. August 28, 2
2001-08-28
Hexacoordinated ruthenium or osmium carbene catalysts
Grant 6,077,805 - Van Der Schaaf , et al. June 20, 2
2000-06-20
Thermal metathesis polymerization process and a polymerisable composition
Grant 6,008,306 - Hafner , et al. December 28, 1
1999-12-28
Two-component catalyst for ROMP
Grant 5,998,326 - Hafner , et al. December 7, 1
1999-12-07
Monomers and composition which can be crosslinked and crosslinked polymers
Grant 5,973,085 - Muhlebach , et al. October 26, 1
1999-10-26
Process for the preparation of catalysts
Grant 5,912,376 - Van Der Schaaf , et al. June 15, 1
1999-06-15
Complexes having optically active ligands, a process for their preparation and their use
Grant 5,047,557 - Hafner , et al. September 10, 1
1991-09-10

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed